Merck, Glenmark Settle With Direct Purchasers In Zetia Case
Drug companies Merck and Glenmark Pharmaceuticals have settled a group of direct purchasers' claims that they gouged drug buyers via an anti-competitive 2010 pay-for-delay patent settlement, leaving one fewer group of...To view the full article, register now.
Already a subscriber? Click here to view full article